论文部分内容阅读
Background Experimental and epidemiological evidences have shown that combined therapy of folic acid is an effective agent for improving endothelial function and lowering plasma homocysteine concentration in cardiovascular disease.However, the efficacy of folic acid supplementation alone on endothelial function and plasma homocysteine concentration in coronary artery disease (CAD) has not been well established.